EU drug watchdog rewrites conflict of interest rules
The European Medicines Agency (EMA) is revising its ‘competing interests’ policy for experts and members of scientific committees. The new rules are expected to be adopted by the… read more.
The European Medicines Agency (EMA) is revising its ‘competing interests’ policy for experts and members of scientific committees. The new rules are expected to be adopted by the… read more.
The European Medicines Agency (EMA) is warning patients and healthcare professionals to beware of pre-filled pens falsely labelled as Ozempic, a diabetes medicine linked to weight loss. National… read more.
The European Medicines Agency (EMA) has authorised several new therapies and vaccines for COVID-19 which offer fresh hope of containing the two-year old pandemic, the EU drug watchdog… read more.
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of… read more.